← Back to Analyst Consensus 
DRTS Buy
Alpha Tau Medical Ltd.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 24, 2026 (29 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 3, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 11, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 22, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jul 16, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 4, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 4, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jun 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 28, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| May 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 19, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| May 12, 2026 | Ladenburg Thalmann | maintain | Buy → Buy | — | 45% |
| May 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 11, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 4, 2026 | Piper Sandler | downgrade | Overweight → Neutral | — | 54% |
| Feb 24, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Dec 10, 2025 | Citigroup | maintain | Buy → Buy | $7 | 54% |
| Nov 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Oct 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Sep 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Apr 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Mar 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Nov 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Oct 23, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Oct 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Aug 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Aug 15, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $7 | 54% |
| Jun 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Mar 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Mar 8, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $7 | 54% |
| Dec 15, 2023 | Citigroup | initiate | — → Buy | $8 | 54% |
| Nov 20, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Nov 17, 2023 | Piper Sandler | maintain | Overweight → Overweight | $8 | 54% |
| Sep 20, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Aug 29, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Aug 29, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $23 | 50% |
| Aug 18, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 24, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 18, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Apr 24, 2023 | HC Wainwright & Co. | initiate | — → Buy | $9 | 44% |
| Nov 23, 2022 | Piper Sandler | maintain | — → Overweight | $12 | 54% |
| Apr 14, 2022 | Cantor Fitzgerald | initiate | — → Overweight | $20 | 50% |
| Apr 8, 2022 | Piper Sandler | initiate | — → Overweight | $19 | 54% |
| Apr 4, 2022 | Citigroup | initiate | — → Buy | $21 | 54% |
Price Target Trend
Jun 13, 2026 Latest: $17.8 Oct 25, 2026
EPS Estimates
0y $-0.96
Lo: $-1.08 Hi: $-0.55
5 analysts ▲1
0q $-0.15
Lo: $-0.16 Hi: $-0.13
4 analysts +1y $-0.53
Lo: $-0.60 Hi: $-0.50
5 analysts ▲1
+1q $-0.15
Lo: $-0.17 Hi: $-0.13
4 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days